Interfacing Integrated Management System (IMS)
Interfacing’s IMS is an AI-enabled platform that combines business process modeling, quality management, controlled documentation, and governance/risk capabilities in a single hub. Organizations rely on IMS to document and automate workflows, maintain versioned records, manage risk programs, and keep compliance activities aligned with regulatory requirements through full lifecycle traceability.
Developed for industries where accountability and oversight are essential, including aerospace, pharma/biotech, finance, and government, IMS delivers operational insight, workflow automation, and intelligent recommendations that help reduce risk and improve quality outcomes. The platform holds ISO 27001 certification and includes 21 CFR Part 11 validation, supporting secure use in high-compliance environments. Additional capabilities include low-code app creation, AI-based process mining, audit management, CAPA and training modules, and performance dashboards. AI improves governance accuracy, strengthens compliance posture, and supports ongoing improvement.
Learn more
Qualio
Qualio is a unified quality and compliance platform that helps growing life sciences companies scale faster while staying continuously audit- and inspection-ready. Medical device, digital health, biotech, and pharma teams use Qualio to replace manual processes and disconnected tools with a single source of truth for quality, regulatory readiness, and risk.
With a modern eQMS at the foundation and Compliance Intelligence layered on top, Qualio moves teams beyond point-in-time audits. Automated gap analysis, cross-standard evidence mapping, and real-time readiness dashboards provide confidence that the organization is prepared today—not just when auditors arrive.
Qualio centralizes document control, training, CAPA, change management, supplier quality, and design controls, linking them directly to regulatory requirements and product lifecycle data. Executive-ready views show compliance health by standard, region, and product, turning regulatory readiness into a measurable business capability instead of a black box.
Compliance Intelligence continuously monitors for risk, highlights gaps early, and prioritizes remediation so teams focus effort where it matters most. Pre-validated regulatory frameworks are maintained as requirements evolve, reducing reliance on consultants and avoiding duplicate work as companies expand.
The result is faster market entry, lower compliance cost, reduced risk of findings or recalls, and confident, risk-managed growth.
Learn more
Redica
Redica is an advanced intelligence cloud platform purpose-built for quality and regulatory teams across the life sciences sector. It addresses the growing complexity of global regulations by transforming vast amounts of compliance data into proactive, decision-ready intelligence. The platform unifies regulatory updates, inspection findings, supplier quality data, and post-market signals in one centralized system. With explainable AI, Redica enables teams to track regulatory changes, understand implications, and take compliant action with confidence. Its inspection intelligence tools help organizations predict outcomes, prepare faster, and benchmark against global inspection trends. Redica also delivers site and supply chain intelligence, offering a 360-degree view of manufacturing and supplier risk. Dynamic risk scoring and red flag alerts allow teams to identify issues before they escalate. Post-market intelligence further supports safety monitoring by detecting trends across recalls, complaints, and enforcement data. By eliminating fragmented workflows and manual tracking, Redica significantly reduces response times. Seamless integrations with platforms like Veeva RIMS enhance collaboration across regulatory and quality teams. Trusted by leading pharmaceutical and biotech companies, Redica helps organizations reduce deviations and costly compliance findings. Overall, the platform empowers teams to move from reactive compliance management to proactive risk prevention.
Learn more
DrugCard
DrugCard is an AI-powered pharmacovigilance platform designed to help pharmaceutical companies, CROs, and drug safety teams automate routine safety intelligence workflows, reduce manual screening, and maintain audit-ready pharmacovigilance processes.
The platform supports global and local medical literature monitoring, regulatory intelligence, and adverse event data management in one connected workflow. DrugCard helps PV teams detect relevant safety information faster, review AI-generated article summaries, prioritize safety-relevant publications, translate local sources, create cases from literature, and maintain full traceability across screening and review activities.
DrugCard’s literature monitoring solution covers 121+ countries, 2,200+ local medical sources, and 100+ languages, combining global sources such as PubMed with local, non-indexed journals that are often difficult to monitor manually. The system provides configurable projects, automated monitoring, keyword highlighting, AI pre-assessment of safety relevance, automated reports, notifications, QC workflows, audit trails, and documentation-ready outputs.
In addition to literature monitoring, DrugCard includes AI-powered Regulatory Intelligence for tracking updates from health authorities and an Adverse Event Database for centralized safety data collection, E2B(R2/R3) support, reporting, analytics, and compliant case management.
DrugCard is built for pharmacovigilance teams that need scalable, transparent, and compliant automation while keeping human experts in control of final medical and regulatory decisions.
Learn more